Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Aruta MG"'
Autor:
Gasperini, G, Alfini, R, Arato, V, Mancini, F, Aruta, MG, Kanvatirth, P, Pickard, D, Necchi, F, Saul, A, Rossi, O, Micoli, F, Mastroeni, P
Typhoid and paratyphoid fevers have a high incidence worldwide and coexist in many geographical areas, especially in low-middle-income countries (LMIC) in South and Southeast Asia. There is extensive consensus on the urgent need for better and afford
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14216bd1bb5ca185f4f7c91852ca8541
Autor:
Alfonso Baldi, Maria Grazia Aruta, Vincenzo Barba, Ciro Menale, Nadia Diano, Ilaria Favicchia, Carla Nicolucci, Stefania Crispi, Damiano Gustavo Mita, Maria Teresa Piccolo
Publikováno v:
Pharmaceutical research (2014). doi:10.1007/s11095-014-1467-3
info:cnr-pdr/source/autori:Menale C.; Piccolo M.T.; Favicchia I.; Aruta M.G.; Baldi A.; Nicolucci C.; Barba V.; Mita D.G.; Crispi S.; Diano N./titolo:Efficacy of Piroxicam Plus Cisplatin-Loaded PLGA Nanoparticles in Inducing Apoptosis in Mesothelioma Cells/doi:10.1007%2Fs11095-014-1467-3/rivista:Pharmaceutical research/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Menale C.; Piccolo M.T.; Favicchia I.; Aruta M.G.; Baldi A.; Nicolucci C.; Barba V.; Mita D.G.; Crispi S.; Diano N./titolo:Efficacy of Piroxicam Plus Cisplatin-Loaded PLGA Nanoparticles in Inducing Apoptosis in Mesothelioma Cells/doi:10.1007%2Fs11095-014-1467-3/rivista:Pharmaceutical research/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
Purpose Combined treatment based on cisplatin-loaded Poly(D,L-lactic-co-glicolic)acid (PLGA) nanoparticles (NP-C) plus the NSAID piroxicam was used as novel treatment for mesothelioma to reduce side effects related to cisplatin toxicity. Methods PLGA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd24033b57afb5ccbfac2914ccf4a289
http://hdl.handle.net/11588/827689
http://hdl.handle.net/11588/827689
Autor:
Mancini F; GSK Vaccines Institute for Global Health S.r.l. (GVGH), 53100 Siena, Italy., Caradonna V; GSK Vaccines Institute for Global Health S.r.l. (GVGH), 53100 Siena, Italy.; Dipartimento di Biotecnologie Mediche, Università degli Studi di Siena, 53100 Siena, Italy., Alfini R; GSK Vaccines Institute for Global Health S.r.l. (GVGH), 53100 Siena, Italy., Aruta MG; GSK Vaccines Institute for Global Health S.r.l. (GVGH), 53100 Siena, Italy., Vitali CG; GSK, 53100 Siena, Italy., Gasperini G; GSK, 53100 Siena, Italy., Piccioli D; GSK, 53100 Siena, Italy., Berlanda Scorza F; GSK Vaccines Institute for Global Health S.r.l. (GVGH), 53100 Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health S.r.l. (GVGH), 53100 Siena, Italy., Micoli F; GSK Vaccines Institute for Global Health S.r.l. (GVGH), 53100 Siena, Italy.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2024 Apr 22; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 22.
Autor:
Di Benedetto R; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy.; Department of Life Sciences, University of Trieste, Trieste, Italy., Mancini F; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Caradonna V; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Aruta MG; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Giannelli C; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Micoli F; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy.
Publikováno v:
Frontiers in molecular biosciences [Front Mol Biosci] 2023 Nov 16; Vol. 10, pp. 1284515. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
Autor:
Rossi O; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Citiulo F; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Giannelli C; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Cappelletti E; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Gasperini G; GSK Global Health Vaccines R&D (GVGH), Siena, Italy.; GSK Vaccines Srl, Siena, Italy., Mancini F; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Acquaviva A; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Raso MM; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Sollai L; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Alfini R; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Aruta MG; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Vitali CG; GSK Vaccines Srl, Siena, Italy., Pizza M; GSK Global Health Vaccines R&D (GVGH), Siena, Italy.; GSK Vaccines Srl, Siena, Italy.; Imperial College, London, United Kingdom., Necchi F; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Rappuoli R; GSK Vaccines Srl, Siena, Italy.; Fondazione Biotecnopolo, Siena, Italy., Martin LB; GSK Global Health Vaccines R&D (GVGH), Siena, Italy.; US Pharmacopoeia, Rockville, Maryland, USA., Berlanda Scorza F; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Colucci AM; GSK Global Health Vaccines R&D (GVGH), Siena, Italy., Micoli F; GSK Global Health Vaccines R&D (GVGH), Siena, Italy. francesca.x.micoli@gsk.com.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2023 Sep 05; Vol. 8 (1), pp. 130. Date of Electronic Publication: 2023 Sep 05.
Autor:
Aruta MG; GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy., Lari E; VisMederi S.r.l., 53100 Siena, Italy., De Simone D; GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy., Semplici B; VisMederi S.r.l., 53100 Siena, Italy., Semplici C; VisMederi S.r.l., 53100 Siena, Italy., Dale H; Malawi Liverpool Wellcome Trust Programme, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK., Chirwa E; Malawi Liverpool Wellcome Trust Programme, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK., Kadwala I; Malawi Liverpool Wellcome Trust Programme, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Mbewe M; Malawi Liverpool Wellcome Trust Programme, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Banda H; Malawi Liverpool Wellcome Trust Programme, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Iturriza-Gomara M; GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy., Gordon M; Malawi Liverpool Wellcome Trust Programme, Blantyre 30096, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK., Nyirenda T; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Piu P; VisMederi S.r.l., 53100 Siena, Italy., Pizza M; GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy.; Imperial College South Kensington Campus, London SW7 2AZ, UK., Berlanda Scorza F; GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy., Grappi S; VisMederi S.r.l., 53100 Siena, Italy., Canals R; GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy., On Behalf Of The Vacc-iNTS Consortium Collaborators
Publikováno v:
Biotech (Basel (Switzerland)) [BioTech (Basel)] 2023 Aug 11; Vol. 12 (3). Date of Electronic Publication: 2023 Aug 11.
Autor:
Aruta MG; GSK Vaccines Institute for Global Health Srl, Via Fiorentina 1, 53100 Siena, Italy., De Simone D; GSK Vaccines Institute for Global Health Srl, Via Fiorentina 1, 53100 Siena, Italy., Dale H; Malawi Liverpool Wellcome Trust Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK., Chirwa E; Malawi Liverpool Wellcome Trust Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK., Kadwala I; Malawi Liverpool Wellcome Trust Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Mbewe M; Malawi Liverpool Wellcome Trust Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Banda H; Malawi Liverpool Wellcome Trust Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre 30096, Malawi.; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Gordon M; Malawi Liverpool Wellcome Trust Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre 30096, Malawi.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L69 3BX, UK., Pizza M; GSK Vaccines Institute for Global Health Srl, Via Fiorentina 1, 53100 Siena, Italy., Berlanda Scorza F; GSK Vaccines Institute for Global Health Srl, Via Fiorentina 1, 53100 Siena, Italy., Nyirenda T; Pathology Department, Kamuzu University of Health Sciences, Blantyre 312225, Malawi., Canals R; GSK Vaccines Institute for Global Health Srl, Via Fiorentina 1, 53100 Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health Srl, Via Fiorentina 1, 53100 Siena, Italy., On Behalf Of The Vacc-iNTS Consortium Collaborators
Publikováno v:
Methods and protocols [Methods Protoc] 2022 Dec 16; Vol. 5 (6). Date of Electronic Publication: 2022 Dec 16.
Autor:
Piccioli D; GSK, Siena, Italy. Electronic address: diego.x.piccioli@gsk.com., Alfini R; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy., Monaci V; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy., Arato V; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy., Carducci M; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy., Aruta MG; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy., Rossi O; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy., Necchi F; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy., Anemona A; GSK, Siena, Italy., Bartolini E; GSK, Siena, Italy., Micoli F; GSK Vaccine Institute for Global Health (GVGH), Siena, Italy.
Publikováno v:
Vaccine [Vaccine] 2022 Oct 19; Vol. 40 (44), pp. 6305-6314. Date of Electronic Publication: 2022 Sep 20.
Autor:
Gasperini G; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Raso MM; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy.; Università di Trieste, Trieste, Italy., Schiavo F; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Aruta MG; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Ravenscroft N; University of Cape Town, Rondebosch, South Africa., Bellich B; Università di Trieste, Trieste, Italy., Cescutti P; Università di Trieste, Trieste, Italy., Necchi F; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy., Rappuoli R; GSK Vaccines, Siena, Italy., Micoli F; GSK Vaccines Institute for Global Health (GVGH), Siena, Italy. francesca.x.micoli@gsk.com.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2022 Jun 30; Vol. 7 (1), pp. 69. Date of Electronic Publication: 2022 Jun 30.
Autor:
Palmieri E; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Kis Z; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.; Department of Chemical and Biological Engineering, The University of Sheffield, Mappin Street, Sheffield S1 3JD, UK., Ozanne J; The National Institute for Biological Standards and Control (NIBSC), South Mimms EN6 3QG, UK., Di Benedetto R; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Ricchetti B; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Massai L; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Carducci M; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Oldrini D; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Gasperini G; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Aruta MG; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy., Kontoravdi C; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK., Shah N; The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK., Mawas F; The National Institute for Biological Standards and Control (NIBSC), South Mimms EN6 3QG, UK., Micoli F; GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100 Siena, Italy.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Jun 28; Vol. 10 (7). Date of Electronic Publication: 2022 Jun 28.